GlassScriptPhysician profile
Terry Luma
NPI 1023350949
$5,353.99
in general payments reported to CMS, 2019-2025
34 companies · $1,717 in 2025
The $1,717 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $161 · 2021: $566 · 2022: $640 · 2023: $1,205 · 2024: $1,066 · 2025: $1,717.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,986 · Education: $2.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,985.71 |
| Education | $2.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $904.50 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $517.26 | 2021-2025 | |
| Glaxosmithkline, LLC. | $454.97 | 2020-2025 | Trelegy Ellipta, Bexsero, Shingrix |
| Astrazeneca Pharmaceuticals LP | $399.78 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $377.99 | 2021-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $317.99 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Dexcom, INC. | $311.92 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $251.48 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Pfizer INC. | $211.06 | 2021-2025 | |
| Exact Sciences Corporation | $203.91 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Daiichi Sankyo INC. | $156.71 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $146.38 | 2022-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $139.43 | 2020-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.09 | 2021-2025 | Jardiance, Tradjenta |
| Lundbeck LLC | $128.58 | 2023-2025 | Rexulti |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.28 | 2020-2023 | Xifaxan |
| Nestle Healthcare Nutrition INC. | $94.69 | 2022-2023 | |
| Aimmune Therapeutics, INC. | $93.28 | 2024-2025 | Zenpep, Vowst |
| Verona Pharma, INC. | $58.08 | 2025 | Ohtuvayre |
| Sumitomo Pharma America, INC. | $43.72 | 2025 | Myfembree, Gemtesa |
| Teva Pharmaceuticals USA, INC. | $35.13 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $34.62 | 2025 | Ultomiris |
| Sanofi-Aventis U.S. LLC | $26.18 | 2025 | |
| Astellas Pharma US INC | $24.85 | 2025 | Veozah |
| Esperion Therapeutics, INC. | $22.40 | 2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $20.67 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $19.63 | 2025 | Opsumit |
| Takeda Pharmaceuticals U.S.A., INC. | $17.27 | 2023 | Trintellix |
| Millicent US INC | $15.03 | 2025 | Femlyv, Intrarosa |
| Bayer Healthcare Pharmaceuticals INC. | $14.95 | 2025 | |
| Axonics, INC. | $14.35 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.04 | 2021 | |
| Supernus Pharmaceuticals, INC. | $13.76 | 2024 | Qelbree |
| Biohaven Pharmaceutical Holding Company LTD. | $12.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Luma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.